Literature DB >> 16304044

Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells.

Maura Calvani1, Annamaria Rapisarda, Badarch Uranchimeg, Robert H Shoemaker, Giovanni Melillo.   

Abstract

Hypoxia is a major pathophysiological condition for the induction of angiogenesis, which is a crucial aspect of growth in solid tumors. In mammalian cells, the transcriptional response to oxygen deprivation is largely mediated by hypoxia-inducible factor 1 (HIF-1), a heterodimer composed of HIF-1alpha and HIF-1beta subunits. However, the response of endothelial cells to hypoxia and the specific involvement of HIF-alpha subunits in this process are still poorly understood. We show that human umbilical vein endothelial cells (HUVECs) cultured in the absence of growth factors survive and form tubelike structures when cultured under hypoxic, but not normoxic, conditions. HUVECs expressed both HIF-1alpha and HIF-2alpha when cultured under hypoxic conditions. Transfection of HIF-1alpha, but not HIF-2alpha, siRNA to HUVECs completely abrogated hypoxic induction of cords. Neutralizing antibodies to bFGF, but not IGF-1, VEGF, or PDGF-BB, blocked survival and sprouting of HUVECs under hypoxic conditions, suggesting the existence of an autocrine loop induced by low oxygen levels. Notably, bFGF-dependent induction of cord formation under normoxic conditions required HIF-1alpha activity, which was also essential for hypoxic induction of bFGF mRNA and protein expression. These results uncover the existence of an HIF-1alpha-bFGF amplification pathway that mediates survival and sprouting of endothelial cells under hypoxic conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304044      PMCID: PMC1895390          DOI: 10.1182/blood-2005-09-3541

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

Authors:  Raju R Raval; Kah Weng Lau; Maxine G B Tran; Heidi M Sowter; Stefano J Mandriota; Ji-Liang Li; Christopher W Pugh; Patrick H Maxwell; Adrian L Harris; Peter J Ratcliffe
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

2.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

3.  Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha.

Authors:  Sang-Ki Park; Agnes M Dadak; Volker H Haase; Lucrezia Fontana; Amato J Giaccia; Randall S Johnson
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

4.  Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia.

Authors:  Andreas P Berger; Kurt Kofler; Jasmin Bektic; Hermann Rogatsch; Hannes Steiner; Georg Bartsch; Helmut Klocker
Journal:  Prostate       Date:  2003-09-15       Impact factor: 4.104

Review 5.  Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.

Authors:  Till Acker; Karl H Plate
Journal:  Cell Tissue Res       Date:  2003-07-29       Impact factor: 5.249

6.  Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs.

Authors:  Michael S Wiesener; Jan Steffen Jürgensen; Christian Rosenberger; Charlotte K Scholze; Jan H Hörstrup; Christina Warnecke; Stefano Mandriota; Ingo Bechmann; Ulrich A Frei; Christopher W Pugh; Peter J Ratcliffe; Sebastian Bachmann; Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  FASEB J       Date:  2002-12-17       Impact factor: 5.191

7.  Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells.

Authors:  Shelley X L Zhang; David Gozal; Leroy R Sachleben; Madhavi Rane; Jon B Klein; Evelyne Gozal
Journal:  FASEB J       Date:  2003-07-03       Impact factor: 5.191

Review 8.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

9.  Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Authors:  Annamaria Rapisarda; Badarch Uranchimeg; Dominic A Scudiero; Mike Selby; Edward A Sausville; Robert H Shoemaker; Giovanni Melillo
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

10.  Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites.

Authors:  Jian Li; Nicholas W Shworak; Michael Simons
Journal:  J Cell Sci       Date:  2002-05-01       Impact factor: 5.235

View more
  77 in total

1.  Nerve growth factor-induced protection of brain capillary endothelial cells exposed to oxygen-glucose deprivation involves attenuation of Erk phosphorylation.

Authors:  Shimon Lecht; Hadar Arien-Zakay; Cezary Marcinkiewicz; Peter I Lelkes; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2009-12-10       Impact factor: 3.444

Review 2.  Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.

Authors:  Nanduri R Prabhakar; Gregg L Semenza
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 3.  Stem Cells in Skin Wound Healing: Are We There Yet?

Authors:  Mariana Teixeira Cerqueira; Rogério Pedro Pirraco; Alexandra Pinto Marques
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-04-01       Impact factor: 4.730

4.  Differential effects of cell adhesion, modulus and VEGFR-2 inhibition on capillary network formation in synthetic hydrogel arrays.

Authors:  Eric H Nguyen; Matthew R Zanotelli; Michael P Schwartz; William L Murphy
Journal:  Biomaterials       Date:  2013-12-11       Impact factor: 12.479

5.  Molecular mechanisms of resistance to tumour anti-angiogenic strategies.

Authors:  Renaud Grépin; Gilles Pagès
Journal:  J Oncol       Date:  2010-03-09       Impact factor: 4.375

Review 6.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

7.  Preserved expression of fibroblast growth factor (FGF)-2 and FGF receptor 1 in brain and spinal cord of amyotrophic lateral sclerosis patients.

Authors:  Susanne Petri; Klaus Krampfl; Kerstin Kuhlemann; Reinhard Dengler; Claudia Grothe
Journal:  Histochem Cell Biol       Date:  2008-12-19       Impact factor: 4.304

8.  Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2.

Authors:  Donggoo Bae; Shaolei Lu; Cherie A Taglienti; Arthur M Mercurio
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

9.  Generation of oxygen gradients with arbitrary shapes in a microfluidic device.

Authors:  Micha Adler; Mark Polinkovsky; Edgar Gutierrez; Alex Groisman
Journal:  Lab Chip       Date:  2009-11-27       Impact factor: 6.799

Review 10.  Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies.

Authors:  Annamaria Rapisarda; Giovanni Melillo
Journal:  Drug Resist Updat       Date:  2009-04-25       Impact factor: 18.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.